I now have all the content needed for a thorough explanation. Here is the complete, well-structured answer:
Module 2 (After Cloning Vectors) - Pharmaceutical Biotechnology (PHBP3050)
Based on your syllabus, Module 2 covers the following topics after cloning vectors:
- Restriction Endonucleases and DNA Ligase
- Recombinant DNA Technology
- Applications of Genetic Engineering in Medicine
- Production of Interferon, Hepatitis-B Vaccine, Insulin
- Polymerase Chain Reaction (PCR)
1. Restriction Endonucleases
Restriction endonucleases (restriction enzymes) are enzymes that cut double-stranded DNA at specific, short sequences called restriction sites. They are the molecular "scissors" of genetic engineering.
Origin and Function
These enzymes were first discovered in bacteria, where they serve as a defense mechanism - they recognize and cleave foreign (viral/phage) DNA, while the host's own DNA is protected by site-specific methylation of the same sequences. Sequence-specific DNA methylases and restriction endonucleases always exist in pairs in the same bacterium.
Naming Convention
Restriction enzymes are named after the organism from which they are isolated:
- EcoRI - from Escherichia coli strain R (first enzyme isolated = I)
- BamHI - from Bacillus amyloliquefaciens H
- HindIII - from Haemophilus influenzae Rd
Format: First letter of genus + first two letters of species + strain designation + roman numeral
Key Common Restriction Enzymes
| Enzyme | Recognition Site | Source Organism |
|---|
| EcoRI | G↓AATTC | E. coli RY13 |
| BamHI | G↓GATCC | Bacillus amyloliquefaciens H |
| HindIII | A↓AGCTT | H. influenzae Rd |
| SmaI | CCC↓GGG (blunt) | Serratia marcescens |
| PstI | CTGCA↓G | Providencia stuartii |
Types of Cuts
- Sticky ends (cohesive ends): The enzyme cuts at staggered positions, leaving short single-stranded overhangs (e.g., BamHI, EcoRI). These are very useful for joining DNA fragments because the overhangs are complementary and can base-pair with each other before ligation.
- Blunt ends: The enzyme cuts directly across both strands at the same position (e.g., SmaI, HpaI). No overhangs are generated.
Frequency of Cutting
The shorter the recognition sequence, the more frequently it cuts:
- 4-bp recognition site → cuts every ~256 bp (4⁴)
- 6-bp recognition site → cuts every ~4,096 bp (4⁶)
- 12-bp recognition site → cuts very rarely (useful for cutting large genomic DNA into a small number of fragments)
- Harper's Illustrated Biochemistry, 32nd Ed.
2. DNA Ligase
DNA ligase is the molecular "glue" - it forms covalent phosphodiester bonds between adjacent DNA fragments. In genetic engineering, bacteriophage T4 DNA ligase is most commonly used.
- It joins the cut ends of vector DNA and the inserted foreign DNA fragment
- Works on both sticky ends (easier - the cohesive overhangs hold the pieces together temporarily) and blunt ends (harder - requires higher enzyme concentration)
- Without ligase, you can cut DNA but cannot create a stable recombinant molecule
3. Recombinant DNA Technology
Recombinant DNA (rDNA) technology is the entire process of isolating, cutting, joining, introducing, and expressing a gene of interest in a host organism to produce a desired protein.
Step-by-Step Process
The core steps are illustrated below:
Step 1 - Obtain the gene of interest:
- Isolate chromosomal DNA from the source organism, OR
- Use reverse transcriptase to convert mRNA into complementary DNA (cDNA) - this approach is preferred when working with eukaryotic genes because cDNA lacks introns
Step 2 - Cut with restriction enzymes:
- Both the vector (e.g., plasmid pUC, pBR322) and the foreign DNA are digested with the same restriction enzyme
- This produces compatible sticky ends on both molecules
Step 3 - Ligation:
- DNA ligase joins the foreign DNA fragment into the linearized vector
- The product is called recombinant DNA (chimeric DNA)
- The collection of all recombinant vectors from a whole genome is called a genomic library; if made from cDNA, it is a cDNA library
Step 4 - Transformation:
- The recombinant plasmid is introduced into a competent host (usually E. coli) by transformation
- Bacteria that took up the plasmid are selected using antibiotic resistance (e.g., ampicillin resistance gene on the vector)
Step 5 - Screening/Selection:
- The lacZ blue-white screening system is commonly used:
- Bacteria with empty vector (no insert) → produce β-galactosidase → blue colonies
- Bacteria with recombinant vector (insert disrupts lacZ gene) → no β-galactosidase → white colonies (desired)
- White colonies are picked and grown - each contains bacteria expressing the desired gene
Step 6 - Expression:
- The host bacteria transcribe and translate the foreign gene
- Large amounts of the desired protein are harvested
- Medical Microbiology 9e; Harper's Illustrated Biochemistry, 32nd Ed.
4. Applications of Genetic Engineering in Medicine
A. Production of Interferon
Interferons (IFNs) are antiviral proteins produced by host cells in response to viral infection. Before rDNA technology, they could only be obtained in tiny quantities from human blood cells - far too little for clinical use.
- The human interferon gene was isolated and cloned into bacterial or yeast expression vectors
- Host cells (E. coli or Saccharomyces cerevisiae) now produce large amounts of recombinant interferon
- Applications: treatment of hepatitis C, multiple sclerosis, hairy cell leukemia, and as antiviral/anticancer agents
- Types produced include IFN-α (Interferon alfa), IFN-β, and IFN-γ
B. Recombinant Hepatitis B Vaccine
The Hepatitis B vaccine is the first vaccine approved for human use produced by recombinant DNA technology.
- The gene encoding Hepatitis B surface antigen (HBsAg) was isolated and cloned into the yeast Saccharomyces cerevisiae
- The yeast expresses and secretes HBsAg protein in large amounts
- This protein is purified and used as the vaccine antigen
- Advantages over older plasma-derived vaccines: safe (no risk of live virus), consistently pure, scalable production
- The immune system produces antibodies against HBsAg, conferring long-term protection against HBV infection
- Medical Microbiology 9e (Jawetz)
C. Recombinant Human Insulin
Before genetic engineering, insulin was extracted from porcine or bovine pancreas - it was foreign protein and caused immune reactions in some patients.
- The human insulin gene was synthesized (since it has introns, the cDNA approach was used)
- The genes for A-chain and B-chain of insulin were separately cloned and expressed in E. coli
- After separate purification, the A and B chains are combined chemically to form active insulin
- Alternatively, human proinsulin cDNA is expressed and then enzymatically converted to active insulin
- Humulin (by Eli Lilly) was the first recombinant human insulin approved (1982) - a landmark in pharmaceutical biotechnology
- It is identical to human insulin, eliminating allergic reactions common with animal-derived insulin
- Harper's Illustrated Biochemistry, 32nd Ed.
5. Polymerase Chain Reaction (PCR)
PCR is a technique that amplifies a specific target DNA sequence exponentially in vitro - making millions of copies from just a single molecule of DNA.
Components Required
| Component | Role |
|---|
| Template DNA | The DNA containing the target sequence |
| Two oligonucleotide primers | Short sequences complementary to the flanking regions of the target on opposite strands |
| Thermostable DNA polymerase (Taq polymerase) | Synthesizes new DNA at high temperatures; withstands denaturation cycles |
| dNTPs (dATP, dTTP, dCTP, dGTP) | Building blocks for new DNA strands |
| Buffer with Mg²⁺ | Provides optimal conditions for polymerase |
Three Steps of Each PCR Cycle
- Denaturation (>90°C): Heat separates the two strands of double-stranded template DNA
- Annealing (50-75°C): The two primers bind (anneal) to their complementary sequences on opposite strands, flanking the target region
- Extension (72°C): Taq DNA polymerase extends from each primer, synthesizing a new DNA strand complementary to the template
Amplification
Each cycle doubles the amount of target DNA:
- 20 cycles = 2²⁰ = ~10⁶ (one million) copies
- 30 cycles = 2³⁰ = ~10⁹ (one billion) copies
- Each cycle takes 5-10 minutes; the process is automated in a thermocycler
Applications of PCR in Pharmacy/Medicine
- Detection of infectious agents - detect viral DNA/RNA even at very low copy numbers (HIV, HBV, HCV, SARS-CoV-2)
- Genetic disease diagnosis - amplify genes to detect mutations (sickle cell disease, cystic fibrosis)
- Forensic medicine - DNA fingerprinting from minimal samples (single hair follicle, blood spot)
- Tissue typing - for organ transplantation compatibility
- Cancer diagnosis - detect oncogene mutations
- Quantitative PCR (qPCR/RT-PCR) - measure gene expression levels and viral load
- Harper's Illustrated Biochemistry, 32nd Ed.; Quick Compendium of Clinical Pathology 5th Ed.
Quick Summary Table for Module 2
| Topic | Key Points |
|---|
| Restriction endonucleases | Cut DNA at specific 4-8 bp palindromic sequences; produce sticky or blunt ends; named after source bacteria |
| DNA ligase | Joins DNA fragments; T4 DNA ligase used in cloning |
| Recombinant DNA technology | Cut → Ligate → Transform → Select → Express |
| Interferon | Produced in E. coli/yeast; antiviral and anticancer uses |
| Hepatitis B vaccine | HBsAg expressed in yeast (S. cerevisiae); first rDNA vaccine |
| Insulin | Human insulin gene expressed in E. coli; Humulin (1982) |
| PCR | Exponential amplification; 3 steps per cycle; Taq polymerase; used in diagnosis, forensics, research |